Your search returned 4 results.

Results
	1.	Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy. [electronic resource] by Beloueche-Babari, M Chung, Y-L Al-Saffar, N M S Falck-Miniotis, M Leach, M O Producer: 20100209 In: British journal of cancer vol. 102 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype. [electronic resource] by Bhattacharya, B Low, S H H Soh, C Kamal Mustapa, N Beloueche-Babari, M Koh, K X Loh, J Soong, R Producer: 20150120 In: British journal of pharmacology vol. 171 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Acquired resistance to EGFR tyrosine kinase inhibitors alters the metabolism of human head and neck squamous carcinoma cells and xenograft tumours. [electronic resource] by Beloueche-Babari, M Box, C Arunan, V Parkes, H G Valenti, M De Haven Brandon, A Jackson, L E Eccles, S A Leach, M O Producer: 20150619 In: British journal of cancer vol. 112 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI. [electronic resource] by Beloueche-Babari, M Jamin, Y Arunan, V Walker-Samuel, S Revill, M Smith, P D Halliday, J Waterton, J C Barjat, H Workman, P Leach, M O Robinson, S P Producer: 20140505 In: British journal of cancer vol. 109 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)